The Repatha® (evolocumab) Cognitive Function Trial (EBBINGHAUS) results are being presented at the American College of Cardiology 66th Annual Scientific Session (ACC.17) by the TIMI Study Group, an academic research organization of Brigham & Women’s Hospital and an affiliate of Harvard Medical School.
The webcast presentation is provided here with the permission of the American College of
Cardiology. The views expressed in the presentation are the views of the presenters.
This presentation has ended. An archive video is available for viewing.